Prostate Cancer Awareness during No Shave November: Early Detection and Targeted Testing

Prostate cancer is one of the most common cancers among men and, according to the American Urological Association (AUA), more than 180,000 men will be diagnosed with prostate cancer this year alone. Understanding various risk factors such as race and family history are important for assessing a patient’s risk profile. One in five African-American men and one in three men with a family history will develop prostate cancer. That’s why generating awareness for prostate cancer and other men’s health topics during No Shave November is so critical. While prostate cancer can be a very serious disease, when detected early and managed appropriately, it can be effectively treated.

Prostate Cancer Facts

One in seven men in the course of their life will be diagnosed with prostate cancer. Only found in males, the prostate is a small, walnut-shaped gland that produces seminal fluid. Some types of prostate cancer grow slowly, but there are other more aggressive types that require chemotherapy, hormone therapy, radiation, surgery, and other forms of treatment.

Prostate cancer symptoms can sometimes include difficulty with urination, but in its early stages there can be no clear symptoms at all. The AUA recommends regular prostate cancer screening every 2 to 4 years to men aged 50 to 69 years. Clinicians should offer prostate cancer screening beginning at age 40 to 45 years for men at increased risk of developing prostate cancer based on the following factors: Black ancestry, germline mutations, or strong family history of prostate cancer.

Prostate Screenings and Early Detection

Early detection is key to the most desirable outcome in the face of a potential cancer diagnosis. Often, early detection begins with a PSA (Prostate Specific Antigen) test. While the PSA screening test can be effective, results can sometimes be abnormal in various non-cancerous, benign conditions and PSA lacks the specificity to distinguish between aggressive forms of prostate cancer and less serious cases. Many  patients can benefit from a more personalized approach to early detection and diagnosis given the variations of the disease and available treatment options.

The 4Kscore® Test is a follow-up blood test after an abnormal age-specific PSA and/or digital rectal exam (DRE) that has a 96.9% sensitivity in assessing the probability of finding an aggressive form of prostate cancer if a biopsy were to be performed. In addition, 4Kscore has been shown to stratify long-term probability of cancer metastasis, or of dying from prostate cancer. Click here to learn more about 4Kscore from OPKO and BioReference®   

For Healthcare Providers: Biomarker tests, like The 4Kscore Test, are useful tools that aid healthcare providers make informed decisions, guide a targeted treatment plan, and help empower patients. Click here to become a client and start ordering 4Kscore and other prostate health tests from OPKO and  BioReference.

References:

  1. https://www.auanet.org/meetings-and-education/prostate-cancer-awareness-month
  2. https://www.auanet.org/guidelines-and-quality/guidelines/early-detection-of-prostate-cancer-guidelines
  3. https://www.auanet.org/meetings-and-education/prostate-cancer-awareness-month/patient-resources
  4. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html
  5. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging.html
  6. https://www.auanet.org/meetings-and-education/prostate-cancer-awareness-month/patient-resources
  7. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging.html

Este sitio web (y las páginas contenidas) estan desactivado. Si se necesita asistencia en español u otro idioma, por favor llame sin cargas a 800 229 5227.

CodeSST
SST Tube
NameSST Tube
CodeBML
Bone Marrow - Lavender Top
NameBone Marrow - Lavender Top
CodeLAV
Lavender top- EDTA
NameLavender top- EDTA
CodeFLUL
Fluid Lavender  (source required)
NameFluid Lavender (source required)
CodeTAN
Tan Top
NameTan Top
CodeYEL
Yellow top- ACD
NameYellow top- ACD
CodeYELS
Yellow top- SPS
NameYellow top- SPS
CodeRBP
Blue-Royal Blue Top K2 EDTA Plasma(*LAVENDER LINE)
NameBlue-Royal Blue Top K2 EDTA Plasma(*LAVENDER LINE)
CodeRBS
Blue-Royal Blue Trace Element Serum (**RED LINE**)
NameBlue-Royal Blue Trace Element Serum (**RED LINE**)
CodeURB
Blue-Royal Urine
NameBlue-Royal Urine
CodeGRY
Grey top- Sodium Fluoride
NameGrey top- Sodium Fluoride
CodeBMG
Bone Marrow - Green Top
NameBone Marrow - Green Top
CodeUG
Green top urine
NameGreen top urine
CodeUGTP
Green top urine (preservative)
NameGreen top urine (preservative)
CodeFLUG
Fluid Green Top
NameFluid Green Top
CodeQFT
Green Top-Lithium Heparin
NameGreen Top-Lithium Heparin
CodeFLUR
Fluid Red Top
NameFluid Red Top
CodeLTB
Light blue top
NameLight blue top
CodePPT
White Top (PPT)
NameWhite Top (PPT)
CodeACDNA
Ariosa Cell-Free DNA (White TopTube)
NameAriosa Cell-Free DNA (White TopTube)
CodeTP
ThinPrep Vial
NameThinPrep Vial
CodeSPTH
Surepath Vial
NameSurepath Vial
CodeO&P
O&P Kit (Total Fix)
NameO&P Kit (Total Fix)
CodeU24
Urine Container - 24hr
NameUrine Container - 24hr
CodeUA
Urine Urinalysis Tube - Yellow
NameUrine Urinalysis Tube - Yellow
CodeCUL
Swab-Bacterial Culture
NameSwab-Bacterial Culture
CodeES
Swab-E
NameSwab-E
CodeAPT
Swab-Aptima Genprobe
NameSwab-Aptima Genprobe
CodeUGP
Urine Container-Genprobe-Aptima
NameUrine Container-Genprobe-Aptima
CodeBDA
Affirm(BD) VPIII
NameAffirm(BD) VPIII
CodeRED
Red Top Plain
NameRed Top Plain
CodeUGY
Urine Tube - Grey Top
NameUrine Tube - Grey Top